Harold Monbouquette
Principal Investigator
University of California, Los Angeles
I'm working on
8 months ago
DNA/RNA-based microbe detection and neurotransmitter sensors
About
The Monbouquette group is creating low-cost, low-power, amplification-free technology for the DNA- or RNA-based detection of microbes; and electrochemical and electroenzymatic microsensors for neurotransmitter monitoring in vivo.
No publications yet
This innovator hasn't added publications yet. In the meantime, you might want to explore their patents, funding, and other profile details.
Rapid Point-of-Care Detection of Human Papillomavirus
Centers for Disease Control and Prevention
•$275,760
•2023
Rapid point-of-care detection of Trichomonas vaginalis
National Institute of Health (NIH)
•$275,731
•2023
Rapid point-of-care detection of Chlamydia trachomatis in urine
National Institute of Health (NIH)
•$149,920
•2021
Development of a low cost point-of-care device for rapid pathogen detection
National Institute of Health (NIH)
•$150,000
•2018 - 2019
Rapid, Binary-Mode Nucleic Acid Sequence Detection
National Science Foundation (NSF)
•$340,515
•2013 - 2016
PCR-Independent, Reagent-Free Nucleic Acid Detection
National Institute of Health (NIH)
•$201,103
•2011 - 2013
Lateral Flow Nucleic Acid Assay with Integrated Pore-Based Detection
Non-provisional
•2021
Apparatus and Method for Electrical Detection of Oligonucleotides through Pore Blockades
Issued
•2016
Harold Monbouquette
Principal Investigator
University of California, Los AngelesWork experience
ElectroNucleics Inc
Principal Investigator
2017 - Present
Top industry applications
Open to opportunities in
BiosensorsDiagnosticsFood SafetyInfectious DiseasesPublic Health
Last updated Mar 2026
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.